Cowen and Company’s Science 37 Holdings, Inc. Common Stock SNCE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-23,313
Closed -$751K 753
2022
Q3
$751K Sell
23,313
-2,042
-8% -$75.7K 0.07% 93
2022
Q2
$1.02M Sell
25,355
-12,411
-33% -$907K 0.1% 97
2022
Q1
$4.04M Sell
37,766
-1,767
-4% -$277K 0.39% 44
2021
Q4
$9.86M Buy
39,533
+2,915
+8% +$647K 0.89% 22
2021
Q3
$7.18M Buy
36,618
+368
+1% +$73.4K 0.34% 35
2021
Q2
$7.25M Buy
+36,250
New +$7.36M 0.38% 33

Other funds holding SNCE

Cowen and Company's SNCE Position: Q4 2022 in Review

Cowen and Company sold out of Science 37 Holdings, Inc. Common Stock (SNCE) in Q4 2022, closing a stake of 23,313 shares — an estimated $751K sold.

Cowen and Company first reported a position in SNCE in Q2 2021 and held it in 6 quarters. The position peaked at $9.86M in Q4 2021. 61 funds tracked by Wall St. Rank hold SNCE as of Q4 2022.

  • Cowen and Company reported no remaining Science 37 Holdings, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Cowen and Company sold 23,313 Science 37 Holdings, Inc. Common Stock shares in Q4 2022, an estimated $751K.
  • Cowen and Company first reported a position in Science 37 Holdings, Inc. Common Stock in Q2 2021 and held it in 6 quarters.
  • Cowen and Company's Science 37 Holdings, Inc. Common Stock position peaked at $9.86M in Q4 2021.
  • 61 funds tracked by Wall St. Rank held Science 37 Holdings, Inc. Common Stock as of Q4 2022.

Based on Cowen and Company's 13F filing for Q4 2022, filed 9 Feb 2023.